ReviewInternational journal of molecular sciences2026
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Bispecific Antibodies in Oncogene-Driven Non-Small-Cell Lung Cancer: Evolving Roles in Treatment Sequencing and Resistance Management.
Saba Musleh Ud Din et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.